Catch-22: Carotid stenting is safe and effective (Food and Drug Administration) but is it reasonable and necessary (Centers for Medicare and Medicaid Services)?

JACC Cardiovasc Interv. 2012 Jun;5(6):694-6. doi: 10.1016/j.jcin.2012.05.001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angioplasty / adverse effects
  • Angioplasty / economics
  • Angioplasty / instrumentation*
  • Asymptomatic Diseases
  • Carotid Artery Diseases / complications
  • Carotid Artery Diseases / economics
  • Carotid Artery Diseases / therapy*
  • Centers for Medicare and Medicaid Services, U.S.* / economics
  • Cost-Benefit Analysis
  • Eligibility Determination
  • Evidence-Based Medicine
  • Health Care Costs
  • Health Care Rationing
  • Humans
  • Insurance, Health, Reimbursement
  • Outcome and Process Assessment, Health Care* / economics
  • Patient Safety
  • Patient Selection
  • Risk Assessment
  • Risk Factors
  • Stents* / economics
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration*